Tower Research Capital (TRC)’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,317
Closed -$18K 5638
2015
Q1
$18K Buy
2,317
+794
+52% +$5.57K ﹤0.01% 2361
2014
Q4
$9K Sell
1,523
-1,796
-54% -$9.68K ﹤0.01% 2305
2014
Q3
$16K Buy
3,319
+2,635
+385% +$14.3K ﹤0.01% 2520
2014
Q2
$4K Sell
684
-97
-12% -$577 ﹤0.01% 3125
2014
Q1
$6K Buy
781
+777
+19,425% +$5.71K ﹤0.01% 3193
2013
Q4
$0 Sell
4
-17,296
-100% -$128K ﹤0.01% 5317
2013
Q3
$134K Buy
17,300
+16,300
+1,630% +$127K 0.01% 1049
2013
Q2
$7K Buy
+1,000
New +$6.29K ﹤0.01% 2750

Tower Research Capital (TRC)'s ELX Position: Q2 2015 in Review

Tower Research Capital (TRC) sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 2,317 shares — an estimated $18K sold.

Tower Research Capital (TRC) first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $134K in Q3 2013. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Tower Research Capital (TRC) reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,317 EMULEX CORP shares in Q2 2015, an estimated $18K.
  • Tower Research Capital (TRC) first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s EMULEX CORP position peaked at $134K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.